Gladius Capital Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$3.13M Buy
+3,400
New +$3.45M 0.14% 81
2025
Q4
Sell
-388
Closed -$371K 107
2025
Q3
$296K Sell
388
-382
-50% -$284K 0.03% 95
2025
Q2
$600K Sell
770
-2,143
-74% -$1.67M 0.22% 48
2025
Q1
$2.41M Sell
2,913
-4,975
-63% -$4.14M 0.64% 40
2024
Q4
$6.09M Buy
7,888
+3,907
+98% +$3.24M 0.65% 33
2024
Q3
$3.53M Buy
3,981
+2,774
+230% +$2.49M 0.43% 43
2024
Q2
$1.09M Buy
1,207
+66
+6% +$52.8K 0.13% 73
2024
Q1
$888K Sell
1,141
-63
-5% -$44.8K 0.29% 75
2023
Q4
$702K Sell
1,204
-1,031
-46% -$602K 0.11% 97
2023
Q3
$1.2M Buy
+2,235
New +$1.15M 0.05% 118
2023
Q2
Sell
-3
Closed -$1.26K 424
2023
Q1
$1.03K Sell
3
-1,218
-100% -$411K ﹤0.01% 367
2022
Q4
$447K Sell
1,221
-572
-32% -$203K 0.03% 103
2022
Q3
$580K Buy
1,793
+1,683
+1,530% +$533K 0.03% 127
2022
Q2
$36K Sell
110
-176
-62% -$52.8K ﹤0.01% 288
2022
Q1
$82K Buy
286
+237
+484% +$61K 0.01% 240
2021
Q4
$14K Buy
+49
New +$12.4K ﹤0.01% 302

Other funds holding LLY

Gladius Capital Management's LLY Position: Q1 2026 in Review

Gladius Capital Management opened a new position in Eli Lilly (LLY) in Q1 2026: 3,400 shares worth $3.13M. The stake represents 0.14% of the portfolio and ranks #81 among its holdings. This is a return to the name: Gladius Capital Management previously reported a position in LLY as recently as Q3 2025.

Gladius Capital Management first reported a position in LLY in Q4 2021 and has held it in 16 quarters since. The position peaked at $6.09M in Q4 2024. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Gladius Capital Management held 3,400 shares of Eli Lilly worth $3.13M as of Q1 2026.
  • Eli Lilly was a new Gladius Capital Management position in Q1 2026.
  • Eli Lilly made up 0.14% of Gladius Capital Management's portfolio in Q1 2026, its #81 holding.
  • Gladius Capital Management first reported a position in Eli Lilly in Q4 2021 and has held it in 16 quarters since.
  • Gladius Capital Management's Eli Lilly position peaked at $6.09M in Q4 2024.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Gladius Capital Management's 13F filing for Q1 2026, filed 7 May 2026.